Answers are grounded in this paper and cite their sources.
T cell receptor (TCR) initiates T cell activation programs that are central to antiviral and antitumor immunity, and TCR-engineered T cell is a promising therapeutic approach in treating solid tumors. However, the design of TCR is time-consuming and labor-intensive, and computational TCR sequence generation remains comparatively underdeveloped with fewer dedicated models. We propose an encoder-decoder generation framework (i.e., Pep2Tcr) warm-started with pretrained peptide and TCR language models to conditionally generate TCR CDR3β sequences targeting a specific peptide. It also incorporates contrastive learning over batches to pull each TCR toward the peptide it pairs with. Through a series of progressive evaluations, Pep2Tcr outperforms other state-of-the-art methods under generation distribution, hit (independent testing sets), authenticity (third-party prediction), and generation probability (OLGA). Grafting and docking experiments of some predicted positive TCR sequences to the HLA-A*02:01-AAGIGILTV (melanoma antigen) complex showed plausible scores and potential interaction patterns for downstream experimental validation.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: